BiOZEEN, a niche bioprocess engineering organization delivering end-to-end solutions to the biopharmaceutical sector across the globe, today announced the appointment of Mr. Mahadevan as the President & Chief Executive Officer (CEO).
Mahadevan most recently served as the Global Director and Commercial leader with Merck Millipore where he led global market segment strategic initiatives. He brings to board over twenty four years of strong understanding of Healthcare and Life Sciences sector.
Dr. Anil Paul Kariath speaking on behalf of the Board of Directors, BiOZEEN expressed his delight on having the versatile leader by stating, ’BiOZEEN identified in Mahadevan a dynamic leader with clarity on visionary and operational skills, both from technology and geography perspective, making him the right match for us.’ He further added that, ’In the past Mr. Mahadevan has executed global strategies with his industry knowledge, strong networking skills and industrial contacts. I believe this will help him steer Biozeen to the next level.’
Mahadevan cites several opportunities for the industry and organization, ’Life Sciences and emerging markets is where the next wave of biotech growth is poised to occur. As a total solutions provider our business model integrates Consulting, Design & Build Equipments and training that would insure productivity and facilitate growth in the bio-pharmaceutical industry as we at BiOZEEN plan to be their unique partner.’
